Skip to content
Recall Observatory FDA recall evidence

Drug product

Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01

D-0090-2023

December 16, 2022

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 91333
Status
Terminated
Classification
Class II
Quantity
13,760 vials
Official record key
drug-enforcement:D-0090-2023

Official wording

Reason: Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

Code information: Lot#: BQ0006, Exp 08/2023

Distribution pattern: USA Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    mislabeled